Speciation, Detection of Virulence Factors and Antibiotic Susceptibility of Coagulase Negative Staphylococci

Document Type : Original Article


1 Department of Microbiology, Government Medical College, Alappuzha, India

2 Department of Microbiology, Government Medical College, Manjeri, India


Background and aim: Coagulase-Negative Staphylococci (CoNS), although predominant in the normal skin flora, can cause severe human diseases, as evident from their increasing incidence in recent years. Detailed characterization of CoNS isolates through speciation, and antibiotic susceptibility may be needed to differentiate pathogenic from contaminating isolates and plan effective therapy. Aim: To isolate and speciate CoNS from various clinical specimens, detect different virulence factors, and determine the antibiotic susceptibility profile.
Materials and methods: A hospital-based cross-sectional study was done using 110 clinical isolates of CoNS throughout one year in the Department of Microbiology, Government Medical College, Thrissur, Kerala, India. The isolates were identified, speciated using standard methods, virulence factors like biofilm formation and DNase were determined, as well as antibiotic susceptibility using the Kirby Bauer disc diffusion method. Statistical analysis was done by counts and percentages using MS Excel version 2010.
Results: Staphylococcus epidermidis was the most frequent isolate, 49.1%, Staphylococcus haemolyticus 27.3%, and Staphylococcus schleiferi 11.8%. Blood samples yielded maximum isolates. Biofilm production by the Congo Red Agar method was seen in 18.2% isolates, and 14.5% showed DNase production. Antibiotic susceptibility testing showed maximum resistance to Penicillin (95.5%) and Erythromycin (80.9%) with Methicillin resistance in 17.3% and 100 % sensitivity to Vancomycin. Biofilm-producing strains were more antibiotic-resistant.
Conclusion: The multiple antibiotic resistance and pathogenic potential of biofilm producers emphasize the importance of developing simple, reliable, and inexpensive methods to identify virulence factors and determine the antibiotic sensitivity of CoNS.


Main Subjects

[1]  Kloos WE, Schleifer KH. Simplified scheme for routine identification of human Staphylococcus species. Journal of clinical microbiology. 1975;1(1):82-8.doi: https://doi.org/10.1128/jcm.1.1.82-88.1975.
[2]  Singh S, Banerjee G, Agarwal SK, Kumar M, Singh RK. Simple method for speciation of clinically significant coagulase negative Staphylococci and its antibiotic sensitivity/resistant pattern in NICU of tertiary care centre. Biomed Res. 2008;19(2):97-101.
[3]  Usha MG, Shwetha DC, Vishwanath G. Speciation of coagulase negative Staphylococcal isolates from clinically significant specimens and their antibiogram. Indian Journal of Pathology and Microbiology. 2013;56(3):258-60. DOI: 10.4103/0377-4929.120383.
[4]  Tammelin A, Domicel P, Hambraeus A, Ståhle E. Dispersal of methicillin-resistant Staphylococcus epidermidis by staff in an operating suite for thoracic and cardiovascular surgery: relation to skin carriage and clothing. Journal of Hospital Infection. 2000;44(2):119-26. https://doi.org/10.1053/jhin.1999.0665.
[5]  Debnath A, Sande S. Speciation and Antibiotic Resistance Pattern of Coagulase Negative Staphylococci (CONS)-Need of Time. International Journal of Health Sciences & Research.2018;8(8):66-73.
[6]  Kavitha Y, Shaik KM. Speciation and antibiogram of clinically significant coagulase negative staphylococci. Internafional Journal of Health Sciences & Research. 2014;4(12):157-61.
[7]  Collee JG, Fraser AG, Marmuin BP, Simmons A, editors. In: Mackie and McCartney’s Practical medical microbiology. 14th ed. Churchill Livingstone: New York; 1996.
[8]  Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Propcop GW, Woods GL. Gram-positive cocci, Part I: Staphylococci and related gram-positive cocci. Color atlas and textbook of diagnostic microbiology, 6th ed. Lippinā€cott Williams and Wilkins. 2006:623-71.
[9]  Forbes BA, Sahm DF, Weissfeld AS. Overview of Bacterial Identification Methods and Strategies. Bailey and Scott’s Diagnostic Microbiology. 12th ed. St.Louis: Mosby Elsevier; 2007. Pp. 216-47.
[10] Freeman J, Platt R, Sidebottom DG, Leclair JM, Epstein MF, Goldmann DA. Coagulase-negative staphylococcal bacteremia in the changing neonatal intensive care unit population: is there an epidemic?. Jama. 1987;258(18):2548-52. doi:10.1001/jama.1987.03400180082031.
[11] Niveditha S, Pramodhini S, Umadevi S, Kumar S, Stephen S. The isolation and the biofilm formation of uropathogens in the patients with catheter associated urinary tract infections (UTIs). Journal of clinical and diagnostic research: JCDR. 2012;6(9):1478-82. doi: 10.7860/JCDR/2012/4367.2537.
[12] CLSI. Performance Standards for Antimicrobial Susceptibility Testing, 28th ed. CLSI Supplement M100. Wayne, PA: USA. Clinical and Laboratory Standards Institute; 2018.
[13] Priya R, Mythili A, Singh YR, Sreekumar H, Manikandan P, Panneerselvam K, et al. Virulence, speciation and antibiotic susceptibility of ocular coagualase negative staphylococci (CoNS). Journal of clinical and diagnostic research: JCDR. 2014;8(5):DC33-37. doi: 10.7860/JCDR/2014/7867.4395.
[14] Kashid RA, Raghuraman K. Speciation and antimicrobial susceptibility of coagulase negative staphylococci, isolated from the anterior nares of health care workers, in a tertiary care hospital in South India, with special reference to methicillin resistance. Int J Contemporary Med Res. 2016;3(8):2329-33.
[15] Sangwan J, Kumari S. Isolation, Identification and Antibiogram of Coagulase Negative Staphylococcus (CoNS) Isolated from Various Clinical Samples at a Tertiary Care Teaching Hospital, Jaipur, India. Int. J. Curr. Microbiol. App. Sci. 2018;7(1):3048-59. https://doi.org/10.20546/ijcmas.2018.701.362.
[16] Samad L, Kakru DK, Fomda BA, Roohi Sh, Lone MS, Ahmed J, et al. Prevalence and risk factors associated with Coagulase Negative Staphylococcus infections in Tertiary care center in North India. International Journal of Current Research and review.2017;9(7):39.
[17] Soumya KR, Philip S, Sugathan S, Mathew J, Radhakrishnan EK. Virulence factors associated with Coagulase Negative Staphylococci isolated from human infections. 3 Biotech. 2017;7(2):140. https://doi.org/10.1007/s13205-017-0753-2.
[18] Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clinical microbiology reviews. 2014;27(4):870-926. DOI: https://doi.org/10.1128/CMR.00109-13.
[19] Asante J, Amoako DG, Abia AL, Somboro AM, Govinden U, Bester LA, et al. Review of clinically and epidemiologically relevant coagulase-negative staphylococci in Africa. Microbial Drug Resistance. 2020;26(8):951-70. https://doi.org/10.1089/mdr.2019.0381.
[20] Naraian R, Singh MP, Ram S. Supplementation of basal substrate to boost up substrate strength and oyster mushroom yield: an overview of substrates and supplements. International Journal of Current Microbiology and Applied Sciences. 2016;5(5):543-53. http://dx.doi.org/10.20546/ijcmas.2016.505.056.
[21] Valli KP, Pramodhini S, Umadevi S, Seetha KS. Speciation and Detection of Virulence Factors of Coagulase Negative Staphylococci Isolated from Various Clinical Samples. Int. J. Curr. Microbiol. App. Sci. 2016;5(4):159-64.
[22] Halim RM, Kassem NN, Mahmoud BS. Detection of biofilm producing staphylococci among different clinical isolates and its relation to methicillin susceptibility. Open access Macedonian journal of medical sciences. 2018;6(8):1335-41. doi: 10.3889/oamjms.2018.246.
[23] Thilakavathy P, Priyan RV, Jagatheeswari PA, Charles J, Dhanalakshmi V, Lallitha S, et al. Evaluation of ica gene in comparison with phenotypic methods for detection of biofilm production by coagulase negative staphylococci in a tertiary care hospital. Journal of clinical and diagnostic research: JCDR. 2015;9(8):DC16-19. doi: 10.7860/JCDR/2015/11725.6371.
[24] Mathur T, Singhal S, Khan S, Upadhyay DJ, Fatma T, Rattan A. Detection of biofilm formation among the clinical isolates of staphylococci: an evaluation of three different screening methods. Indian journal of medical microbiology. 2006;24(1):25-9. https://doi.org/10.1016/S0255-0857(21)02466-X.
[25] Kaiser T, Menezes E, Regina K, et al. Modification of the Congo red agar method to detect biofilm production by Staphylococcus epidermidis. Diag Microbiol Inf Dis. 2013; 75:235– 239. https://doi.org/10.1016/j.diagmicrobio.2012.11.014.
[26] Prasad S, Nayak N, Satpathy G, Nag HL, Venkatesh P, Ramakrishnan S, et al. Molecular & phenotypic characterization of Staphylococcus epidermidis in implant related infections. The Indian journal of medical research. 2012;136(3):483-90.
[27] Quinn PJ, Carter ME, Markey BK, Cartey GE. Clinical Veterinary Microbiology. Section 2. Bacteriology, 8. Staphylococcus species. Mosby-Year Book Europe Limited, Lynton House, London, England.1994: 118–126.
[28] Deighton MA, Franklin JC, Spicer WJ, Balkau B. Species identification, antibiotic sensitivity and slime production of coagulase-negative staphylococci isolated from clinical specimens. Epidemiology & Infection. 1988;101(1):99-113. DOI: https://doi.org/10.1017/S0950268800029265.
[29] Natoli S, Fontana C, Favaro M, Bergamini A, Testore GP, Minelli S, et al. Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options. BMC infectious diseases. 2009;9(1):1-8. https://doi.org/10.1186/1471-2334-9-83.
[30] Sateesh K, Anandam s, Pai V. Speciation and Antimicrobial Susceptibility Pattern of Clinically Significant Coagulase Negative Staphylococci in a Tertiary Health Care Centre.Sch. J. App. Med. Sci. 2017; 5:3371-3376. DOI: 10.21276/sjams.
Volume 3, Issue 3
September 2021
Pages 122-132
  • Receive Date: 19 June 2021
  • Revise Date: 09 August 2021
  • Accept Date: 25 August 2021
  • First Publish Date: 01 September 2021